These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22976234)

  • 1. Automated determination of brain parenchymal fraction in multiple sclerosis.
    Vågberg M; Lindqvist T; Ambarki K; Warntjes JB; Sundström P; Birgander R; Svenningsson A
    AJNR Am J Neuroradiol; 2013 Mar; 34(3):498-504. PubMed ID: 22976234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain parenchymal fraction in an age-stratified healthy population - determined by MRI using manual segmentation and three automated segmentation methods.
    Vågberg M; Ambarki K; Lindqvist T; Birgander R; Svenningsson A
    J Neuroradiol; 2016 Dec; 43(6):384-391. PubMed ID: 27720265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements.
    Sampat MP; Healy BC; Meier DS; Dell'Oglio E; Liguori M; Guttmann CR
    Neuroimage; 2010 Oct; 52(4):1367-73. PubMed ID: 20362675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors.
    Dell'Oglio E; Ceccarelli A; Glanz BI; Healy BC; Tauhid S; Arora A; Saravanan N; Bruha MJ; Vartanian AV; Dupuy SL; Benedict RHB; Bakshi R; Neema M
    J Neuroimaging; 2015; 25(2):191-199. PubMed ID: 25523616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques.
    Durand-Dubief F; Belaroussi B; Armspach JP; Dufour M; Roggerone S; Vukusic S; Hannoun S; Sappey-Marinier D; Confavreux C; Cotton F
    AJNR Am J Neuroradiol; 2012 Nov; 33(10):1918-24. PubMed ID: 22790248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients.
    Nakamura K; Fisher E
    Neuroimage; 2009 Feb; 44(3):769-76. PubMed ID: 19007895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis.
    Derakhshan M; Caramanos Z; Giacomini PS; Narayanan S; Maranzano J; Francis SJ; Arnold DL; Collins DL
    Neuroimage; 2010 Oct; 52(4):1261-7. PubMed ID: 20483380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique.
    Sati P; Cross AH; Luo J; Hildebolt CF; Yablonskiy DA
    Neuroimage; 2010 Jul; 51(3):1089-97. PubMed ID: 20338247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis.
    Cobzas D; Sun H; Walsh AJ; Lebel RM; Blevins G; Wilman AH
    J Magn Reson Imaging; 2015 Dec; 42(6):1601-10. PubMed ID: 25980643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
    Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
    J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-brain atrophy assessed by proportional- versus registration-based pipelines from 3T MRI in multiple sclerosis.
    Hemond CC; Chu R; Tummala S; Tauhid S; Healy BC; Bakshi R
    Brain Behav; 2018 Aug; 8(8):e01068. PubMed ID: 30019857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis.
    Zivadinov R; Banas AC; Yella V; Abdelrahman N; Weinstock-Guttman B; Dwyer MG
    AJNR Am J Neuroradiol; 2008 Feb; 29(2):319-25. PubMed ID: 17974604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis lesion segmentation using an automatic multimodal graph cuts.
    García-Lorenzo D; Lecoeur J; Arnold DL; Collins DL; Barillot C
    Med Image Comput Comput Assist Interv; 2009; 12(Pt 2):584-91. PubMed ID: 20426159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using multiple imputation to efficiently correct cerebral MRI whole brain lesion and atrophy data in patients with multiple sclerosis.
    Chua AS; Egorova S; Anderson MC; Polgar-Turcsanyi M; Chitnis T; Weiner HL; Guttmann CR; Bakshi R; Healy BC
    Neuroimage; 2015 Oct; 119():81-8. PubMed ID: 26093330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
    Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
    J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis.
    Liptak Z; Berger AM; Sampat MP; Charil A; Felsovalyi O; Healy BC; Hildenbrand P; Khoury SJ; Weiner HL; Bakshi R; Guttmann CR
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):1465-70. PubMed ID: 18556361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gadolinium contrast agent administration on automatic brain tissue classification of patients with multiple sclerosis.
    Warntjes JB; Tisell A; Landtblom AM; Lundberg P
    AJNR Am J Neuroradiol; 2014 Jul; 35(7):1330-6. PubMed ID: 24699093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
    Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
    Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis.
    Neema M; Goldberg-Zimring D; Guss ZD; Healy BC; Guttmann CR; Houtchens MK; Weiner HL; Horsfield MA; Hackney DB; Alsop DC; Bakshi R
    Neuroimage; 2009 Jul; 46(3):633-41. PubMed ID: 19281850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation.
    Sharma J; Sanfilipo MP; Benedict RH; Weinstock-Guttman B; Munschauer FE; Bakshi R
    AJNR Am J Neuroradiol; 2004; 25(6):985-96. PubMed ID: 15205136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.